Find a Clinical Trial

Find a clinical trial underway at the OSUCCC – James.

Search by Keyword

(i.e. John Smith, 197102, Phase 3)

Showing 1-10 of 19

Filtered By: BMT

Open To Accrual

Safety, PK, PD, Dosing, and Efficacy of RLS-0071for the Treatment of Hospitalized Patients With Steroid-Refractory Acute Graft-versus-Host Disease

Protocol NumberOSU-24157

Open To Accrual

A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma

Protocol NumberOSU-23331

Open To Accrual

A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

Protocol NumberOSU-23362

Open To Accrual

Genetically Engineered Cells (Anti-CD19/CD20/CD22 CAR T-cells) for the Treatment of Relapsed or Refractory Lymphoid Malignancies

Protocol NumberOSU-21170

Open To Accrual

Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma

Protocol NumberOSU-20103

Open To Accrual

Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma

Protocol NumberOSU-23426

Open To Accrual

CC-99282 + Rituximab Early Post CART for Non-Hodgkin's Lymphoma

Protocol NumberOSU-23214

Open To Accrual

Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant

Protocol NumberOSU-23264

Open To Accrual

HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

Protocol NumberOSU-23416

Open To Accrual

Safety Study of Unlicensed IND Cord Blood Units Manufactured by the National Cord Blood Program for Unrelated Transplantation

Protocol NumberOSU-12097